1. Anden, N. E., Dahlstrom, A., Fuxe, K., Hokfelt, T.: The effect of haloperidol and chlorpromazine on the amine levels of central monoamine neurons. Acta physiol. scand. 68, 449?504 (1966)
2. Anden, N. E., Butcher, S. G., Corrodi, A., Fuxe, K., Understedt, U.: Receptor activity and turnover of dopamine and noradrenaline after neuroleptics. Europ. J. Pharmacol. 11, 303?306 (1970)
3. Bartholini, G., Tissot, R., Pletscher, A.: III. Symp. Parkinson Dis., Edinburgh 1968, F. J. Gillingham and I. M. L. Douvedson eds., cited by U. Scapagnini: Psychotropic drugs and neuroendocrine function. New York: Pergamon Press (in press)
4. Bissel, C. V., Scott, A. L., Farnsworth, W. H., Winkler, I.: A preliminary study of the use of 2-methyl-1,2-bis(3-pyridil)1-propanone (SU 4885). N.Y. St. J. Med. 1, 3596?3603 (1959)
5. Brambilla, F., Cazzullo, C. L., Penati, G.: Les hormones et la schizophrenie. Problèmes actuels de endocrinologie, pp. 273?297. Paris: Expansion scientifique 1974